|本期目录/Table of Contents|

[1]倪晶晶,周晓美综述,苏亦平审校.抗苗勒管激素在卵巢恶性肿瘤诊治中的应用[J].医学研究与战创伤救治(原医学研究生学报),2019,21(3):277-281.[doi:10.3969/j.issn.1672-271X.2019.03.012]
　NI Jing-jing,ZHOU Xiao-mei reviewing,SU Yi-ping checking.Application of anti-mullerian hormone in diagnosis and treatment of ovarian malignant tumor[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(3):277-281.[doi:10.3969/j.issn.1672-271X.2019.03.012]
点击复制

抗苗勒管激素在卵巢恶性肿瘤诊治中的应用()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第21卷
期数:
2019年3期
页码:
277-281
栏目:
综述
出版日期:
2019-05-10

文章信息/Info

Title:
Application of anti-mullerian hormone in diagnosis and treatment of ovarian malignant tumor
文章编号:
1672-271X（2019）03-0277-05
作者:
倪晶晶;  周晓美综述;  苏亦平审校
作者单位：210004 南京，南京医科大学附属妇产医院(南京市妇幼保健院)妇科[倪晶晶(医学硕士研究生)、周晓美、苏亦平]
Author(s):
NI Jing-jing;  ZHOU Xiao-mei reviewing;  SU Yi-ping checking
(Department of Gynecology，Obstetrics and Gynecology Hospital，the Affiliated Hospital of Nanjing Medical University， Nanjing 210004，Jiangsu，China)
关键词:
抗苗勒管激素;  卵巢颗粒细胞瘤;  卵巢上皮性癌;  卵巢功能保护
Keywords:
anti-mullerian hormone;  granulosa cell tumor;  epithelial ovarian cancer;  protection of ovarian function
分类号:
R737.31
DOI:
10.3969/j.issn.1672-271X.2019.03.012
文献标志码:
A
摘要:
抗苗勒管激素（AMH）是由睾丸支持细胞和卵泡颗粒细胞合成的糖蛋白二聚体，通过与靶细胞膜上的特异性受体结合而发挥作用，是性腺发育及男性性别分化的重要调节因子，对卵泡成熟的调控也有重要作用，故其在生殖内分泌领域一直备受关注。近年来，越来越多研究发现AMH与某些妇科恶性肿瘤相关，在卵巢颗粒细胞瘤的诊断、治疗、随访及监测中的作用日益突显，且对AMH受体阳性卵巢上皮性癌细胞的生长、侵袭、转移及耐药有抑制作用，有望成为特定妇科恶性肿瘤治疗的新药物，并且对于年轻癌症者生育功能的保护，也有一定益处。文章主要对AMH在卵巢颗粒细胞瘤的诊治、卵巢上皮性癌的治疗及年轻癌症患者卵巢功能保护的临床应用进行综述。
Abstract:
Anti-mullerian hormone (AMH) is a glycoprotein hormone produced by Sertoli cells of the testis and granulosa cells of the ovary. To play its biological function, AMH binds to its specific receptors on target cell membranes. AMH is a vital regulator of gonadal development and male sex differentiation , it also plays an important role in regulating follicular maturation. Therefore, AMH has been receiving much attention in the field of Reproductive medicine and Endocrinology. Recently, more and more studies have revealed that AMH has a certain relationship with some gynecological malignancy. Its role in the diagnosis, treatment, follow-up and monitoring of granulosa cell tumor becomes increasingly prominent.Furthermore, it exhibits an inhibitory effect on the proliferation, invasion, metastasis and drug resistance of AMHR-positive tumors, showing its potential to be a novel anticancer agent for gynecologic tumors. It is also beneficial for the protection of fertility in those young women suffering from cancers. This article reviews the clinical application of AMH in ovarian granulosa cell tumor, ovarian epithelial cancer and ovarian function protection.

参考文献/References:

1 LeeMM,DonahoePK.Mullerian inhibiting substance:a gonadal hormone with multiple functions [J].Endocr Rev,1993,14(2):152-164.
2 王昱普,刘国敏,赵志伟,等.抗苗勒管激素的研究及应用进展[J].四川解剖学杂志,2016,24(4):25-32,46.
3 VisserJA,ThemmenAP.Anti-Müllerian hormone and folliculogenesis[J]. Mol Cell Endocrinol,2005,234(1-2):81-86.
4 VisserJA.AMH signaling: from receptor to target gene[J]. Mol Cell Endocrinol,2003,211(1-2):65-73.
5 McGuireS.World Cancer Report 2014.Geneva,Switzerland:World Health Organization,nternational Agency for Research on Cancer,WHO Press,2015[J].Adv Nutr,2016,7(2):418-419.
6 PectasidesD, PectasidesE, PsyrriA. Granulosa cell tumor of the ovary[J].Cancer Treat Rev,2008,34(1):1-12.
7 袁海琳,曾华英,陈亚梅.卵巢颗粒细胞瘤研究新进展[J].国外医学(妇产科学分册),2007,34(3):203-206.
8 GustafsonML,LeeMM, ScullyRE, et al. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor[J].N Engl J Med,1992,326(7):466-471.
9 La MarcaA, VolpeA. The Anti-Mullerian hormone and ovarian cancer[J]. Hum Reprod Update,2007,13(3):265-273.
10 ChangHL,PahlavanN,HalpernEF,et al.Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology[J].Gynecol Oncol,2009,114(1):57-60.
11 HaltiaUM,HallamaaM,TapperJ,et al.Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors[J].Gynecol Oncol,2017,144(1):83-89.
12 龙雯晴,王伟民,RodolfoREY,等.抗苗勒管激素作为卵巢颗粒细胞瘤肿瘤标记物的实验研究[J].中华妇产科杂志,2000,35(6):34-36.
13 梁晓艳,姚汉武,马晓宇.卵巢颗细胞瘤中AMH的表达及其组织学分级标准的分析评价[J].中国医药导报,2010,7(8):59-61.
14 AnttonenM,Unkila-KallioL,LeminenA,et al.High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors[J].J Clin Endocrinol Metab,2005,90(12):6529-6535.
15 AnttonenM,F?rkkil?A,TaurialaH, et al.Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis[J].Lab Invest,2011,91(11):1605-1614.
16 卢淮武,林荣春,林仲秋.2017 NCCN《卵巢癌临床实践指南(第一版)》解读[J].中国实用妇科与产科杂志,2017,33(5):485-493.
17 HinesJF KM,MooreJL,FineKP,et al.Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis:a case report and review of the literature[J]. Gynecol Oncol， 1996,60:484-488.
18 GeertsI, VergoteI, NevenP, et al.The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors[J].Int J Gynecol Cancer,2009,19(5):847-855.
19 F?rkkil?A,KoskelaS, BrykS, et al.The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B[J].Int J Cancer,2015,137(7):1661-1671.
20 JungS,AllenN,ArslanAA,et al.Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts[J].Int J Cancer,2018,142(2):262-270.
21 WalentowiczP,SadleckiP,KrintusM,et al.Serum anti-müllerian hormone levels in patients with epithelial ovarian cancer[J].Int J Endocrinol,2013,2013:517239.
22 杨帆,谢树红,黄惠娟.卵巢癌在代谢组学中的研究进展[J].东南国防医药,2018,20(2):160-163.
23 MasiakosPT,MacLaughlinDT,MaheswaranS,et al.Human ovarian cancer,cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor,bind,and are responsive to MIS[J].Clin Cancer Res,1999,5(11):3488-3499.
24 StephenAE,PearsallLA,ChristianBP,et al.Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo[J].Clin Cancer Res,2002,8(8):2640-2646.
25 Pieretti-VanmarckeR,DonahoePK,SzotekP,et al.Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo[J].Clin Cancer Res,2006,12(5):1593-1598.
26 LiangJ,WuYL,ChenBJ,et al.The C-kit receptor-mediated signal transduction and tumor-related diseases[J].Int J Biol Sci,2013,9:435-443.
27 MeirellesK,BenedictLA,DombkowskiD,et al.Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance[J].Proc Natl Acad Sci USA,2012,109(7):2358-2363.
28 ZhangT,DengL,XiongQ,et al.Anti-Müllerian hormone inhibits proliferation and induces apoptosis in epithelial ovarian cancer cells by regulating the cell cycle and decreasing the secretion of stem cell factor[J].Oncol Lett,2018,16(3):3260-3266.
29 MeirowD,DorJ,KaufmanB,et al.Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy.Potential mechanisms of ovarian injury[J].Hum Reprod,2007,22(6):1626-1633.
30 PeignéM,DecanterC.Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review[J].Reprod Biol Endocrinol,2014,12:26.
31 La MarcaA,SighinolfiG,GiuliniS,et al.Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles[J].Reprod Biomed Online,2010,21(4):463-469.
32 AndersonRA,RosendahlM,KelseyTW,et al.Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer[J].Eur J Cancer,2013,49(16):3404-3011.
33 韩国庆,梁元姣.抗苗勒氏管激素在女性生殖系统中的研究进展[J].东南国防医药,2018,20(5):527-531.
34 Kalich-PhilosophL,RonessH,CarmelyA,et al.Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility[J].Sci Transl Med,2013,5(185):185ra62.
35 GoldmanKN,ChenetteD,ArjuR,et al.mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy[J].Proc Natl Acad Sci USA,2017,114(12):3186-3191.
36 KanoM,SosulskiAE,ZhangL,et al.AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy[J].Proc Natl Acad Sci USA,2017,114(9):E1688-E1697.

相似文献/References:

[1]刘康生,王培,陈亚军.抗苗勒管激素与基础性激素相关性及其在孕前育龄女性中的应用价值[J].医学研究与战创伤救治(原医学研究生学报),2018,20(03):289.[doi:10.3969/j.issn.1672-271X.2018.03.016]

备注/Memo

备注/Memo:
收稿日期：2018-12-27
更新日期/Last Update: 2019-05-10